 - Receipt of long-term greater than or equal to 2 weeks potentially immunosuppressive corticosteroid use within six months or anticipated receipt during the study period. Specifically, potentially immunosuppressive corticosteroids or any parenteral corticosteroid, high dose 800 mcgday beclomethasone dipropionate or equivalent medication; nasal and topical steroids are allowed. 